IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 127 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $938,734 | -4.4% | 153,639 | 0.0% | 0.69% | +14.6% |
| Q4 2022 | $981,753 | -33.3% | 153,639 | 0.0% | 0.60% | -4.7% |
| Q3 2022 | $1,472,000 | -13.6% | 153,639 | -0.5% | 0.63% | -33.2% |
| Q2 2022 | $1,704,000 | -13.9% | 154,356 | +29.9% | 0.95% | +2.6% |
| Q1 2022 | $1,979,000 | -42.4% | 118,856 | -34.0% | 0.92% | -35.9% |
| Q4 2021 | $3,436,000 | -62.8% | 179,995 | -51.9% | 1.44% | -55.7% |
| Q3 2021 | $9,235,000 | +137.4% | 374,495 | +150.5% | 3.26% | +109.5% |
| Q2 2021 | $3,890,000 | +25.9% | 149,495 | +53.2% | 1.56% | +39.6% |
| Q1 2021 | $3,089,000 | -59.6% | 97,574 | -40.8% | 1.11% | -46.5% |
| Q4 2020 | $7,647,000 | -26.3% | 164,800 | -47.7% | 2.08% | -26.1% |
| Q3 2020 | $10,370,000 | -36.0% | 315,000 | -46.6% | 2.82% | -39.8% |
| Q2 2020 | $16,196,000 | +35.4% | 590,000 | +47.7% | 4.68% | -19.3% |
| Q1 2020 | $11,959,000 | -34.2% | 399,500 | -39.1% | 5.80% | +28.8% |
| Q4 2019 | $18,172,000 | +37.2% | 656,500 | -9.8% | 4.50% | -52.9% |
| Q3 2019 | $13,241,000 | -77.7% | 727,500 | -70.0% | 9.56% | -54.8% |
| Q2 2019 | $59,503,000 | +112.5% | 2,426,701 | -17.6% | 21.16% | +58.9% |
| Q1 2019 | $27,999,000 | +4.8% | 2,944,201 | -2.5% | 13.31% | -34.7% |
| Q4 2018 | $26,720,000 | +6.9% | 3,019,201 | +35.8% | 20.38% | +128.5% |
| Q3 2018 | $25,005,000 | -53.7% | 2,222,701 | -47.3% | 8.92% | -7.1% |
| Q2 2018 | $53,952,000 | -28.5% | 4,215,000 | -5.6% | 9.60% | -22.0% |
| Q1 2018 | $75,430,000 | +141.6% | 4,463,300 | +14.4% | 12.32% | +109.0% |
| Q4 2017 | $31,224,000 | +17.4% | 3,903,000 | +13.7% | 5.90% | +23.7% |
| Q3 2017 | $26,597,000 | -3.2% | 3,431,809 | -8.2% | 4.77% | -38.0% |
| Q2 2017 | $27,482,000 | – | 3,739,044 | – | 7.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |